ADDC provided the opportunity to its members to access AstraZeneca's high quality compound library through a competitive Request for Proposals process. Read the full story

Spark Therapeutics pharma alliances with big pharma giant Pfizer to develop and commercialize SPK-FIX, a potential treatment for hemophilia B. Read the full story

Bristol-Myers Squibb signed a pharma deal for an exclusive option to acquire Galecto Biotech and gain worldwide rights to its lead asset TD139. Read the full story

Triphase Accelerator announced a new strategic pharma deal with Celgene. Read the full story

IMS Health becomes pharma partner with UCB to help deliver greater business insights and improved operations, leveraging IMS Health’s Nexxus Commercial Application Suite and the IMS One intelligent cloud. Read the full story

Pharmacyclics has entered into a pharma alliance agreement with Roche to evaluate the safety, tolerability and preliminary efficacy of IMBRUVICA (ibrutinib)in combination with GAZYVA (obinutuzumab). Read the full story

Selecta Biosciences JDRF have extended their pharma partnership and attracted Sanofi as a partner in support of their program to develop a Synthetic Vaccine Particle immunotherapy with the long-term goal to treat and potentially prevent the underlying cause of type 1 diabetes. Read the full story

Astellas Pharma announced a pharma alliance with an investigator at Harvard Medical School focused on discovering the pathologic mechanism for retinitis pigmentosa and identification of new therapeutic targets. Read the full story

BMS, Pharmacyclics and Janssen R&D have started a pharma alliance for Opdivo and Imbruvica evaluation. Read the full story

The University of Texas MD Anderson Cancer Center announced it formed a research alliance with GlaxoSmithKline to strengthen its efforts in advancing therapies that train the body's immune system to combat cancer. Read the full story